Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walraven

Showing results (631-640 of 803) with videos related to

Pageof 81
Sort By:
JACC. Cardiovascular Interventions|November 25, 2017
1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal BypassMichel M P J Reijnen, Laurens A van Walraven, Wilbert M Fritschy, et al.
Circulation. Cardiovascular Quality and Outcomes|March 25, 2024
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized TrialsSachin J Shah, Carl van Walraven, Sun Young Jeon, et al.
Journal of Human Hypertension|August 30, 2000
Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communitiesM A van der Sande, P J Milligan, O A Nyan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2016
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximabIris Walraven, Michel van den Heuvel, Judi van Diessen, et al.
BMJ Open|September 21, 2016
Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort studySimone P Rauh, Femke Rutters, Brian L Thorsted, et al.
ESMO Open|January 18, 2023
Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedureE Feldman, F J Pos, R J Smeenk, et al.
Bone Marrow Transplantation|December 22, 2009
Family donor care management: principles and recommendationsS M van Walraven, G Nicoloso-de Faveri, U A I Axdorph-Nygell, et al.
Clinical Trials (London, England)|June 16, 2023
Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren't so simpleNoelle M Cocoros, Jerry H Gurwitz, Mark J Cziraky, et al.
Physics and Imaging in Radiation Oncology|August 6, 2021
The impact of image acquisition time on registration, delineation and image quality for magnetic resonance guided radiotherapy of prostate cancer patientsM E Nowee, V W J van Pelt, I Walraven, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 12, 2020
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapyDaphne M V Huizing, Else A Aalbersberg, Michelle W J Versleijen, et al.
Pageof 81

Showing results (631-640 of 803) with videos related to

Sort By:
Pageof 81
JACC. Cardiovascular Interventions|November 25, 2017
1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal BypassMichel M P J Reijnen, Laurens A van Walraven, Wilbert M Fritschy, et al.
Circulation. Cardiovascular Quality and Outcomes|March 25, 2024
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized TrialsSachin J Shah, Carl van Walraven, Sun Young Jeon, et al.
Journal of Human Hypertension|August 30, 2000
Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communitiesM A van der Sande, P J Milligan, O A Nyan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2016
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximabIris Walraven, Michel van den Heuvel, Judi van Diessen, et al.
BMJ Open|September 21, 2016
Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort studySimone P Rauh, Femke Rutters, Brian L Thorsted, et al.
ESMO Open|January 18, 2023
Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedureE Feldman, F J Pos, R J Smeenk, et al.
Bone Marrow Transplantation|December 22, 2009
Family donor care management: principles and recommendationsS M van Walraven, G Nicoloso-de Faveri, U A I Axdorph-Nygell, et al.
Clinical Trials (London, England)|June 16, 2023
Pragmatic guidance for embedding pragmatic clinical trials in health plans: Large simple trials aren't so simpleNoelle M Cocoros, Jerry H Gurwitz, Mark J Cziraky, et al.
Physics and Imaging in Radiation Oncology|August 6, 2021
The impact of image acquisition time on registration, delineation and image quality for magnetic resonance guided radiotherapy of prostate cancer patientsM E Nowee, V W J van Pelt, I Walraven, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 12, 2020
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapyDaphne M V Huizing, Else A Aalbersberg, Michelle W J Versleijen, et al.
Pageof 81